The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
GCISAVE: A non-comparative randomized phase II study of combination of gemcitabine cisplatin (GCis) +/- avelumab (A) in 1st line treatment for locally advanced or metastatic urothelial bladder carcinoma (MUBC)—GETUG AFU V07.
 
Marine Gross-Goupil
Consulting or Advisory Role - Amgen; amgen; Astellas Medivation; AstraZeneca; Bayer/Onyx; Bristol-Myers Squibb; ipsen; Janssen-Cilag; MSD Oncology; Pfizer; Roche; Sanofi
Research Funding - Astrazeneca (Inst); Astrazeneca (Inst); BMS (Inst); ipsen (Inst); Janssen-Cilag (Inst); Merck (Inst); MSD Oncology (Inst); Pfizer (Inst); Roche (Inst)
Travel, Accommodations, Expenses - Astellas Pharma; AstraZeneca; AstraZeneca; Ipsen; ipsen; ipsen; ipsen; Janssen-Cilag; MSD Oncology; MSD Oncology; pfizer; Pfizer; Roche
Other Relationship - Janssen
 
Eric Frison
No Relationships to Disclose
 
Guilhem Roubaud
Travel, Accommodations, Expenses - Janssen
 
Aude Flechon
Honoraria - AAA HealthCare; Astellas Pharma; AstraZeneca; Bayer; BMS; Gilead Sciences; Ipsen; Janssen-Cilag; MSD Oncology; NOVARTIS; PFIZER; Roche/Genentech; Sanofi/Aventis
Travel, Accommodations, Expenses - AAA HealthCare; Astellas Pharma; AstraZeneca; Bayer; BMS; IPSEN; Janssen-Cilag; MSD Oncology; Pfizer; Roche/Genentech; Sanofi/Aventis
 
Fabien Calcagno
No Relationships to Disclose
 
Frederic Rolland
Consulting or Advisory Role - Eisai; Ipsen; Merck KGaA; MSD Oncology; Pfizer
Travel, Accommodations, Expenses - Ipsen; Merck KGaA; Merck KGaA; MSD Oncology; Mundipharma; Pfizer
 
Florence Joly
Consulting or Advisory Role - 3A Pharmaceuticals & Diagnostics; Amgen; Astellas Pharma; AstraZeneca; Bayer; Bristol-Myers Squibb; Clovis Oncology; Eisai; GlaxoSmithKline; Ipsen; Janssen; MSD Oncology; Pfizer; Seagen
Travel, Accommodations, Expenses - AstraZeneca; BMS; Eisai; GlaxoSmithKline; Ipsen; Janssen; MSD Oncology
 
Anne-Aurelie Raymond
No Relationships to Disclose
 
Guillaume Chotard
No Relationships to Disclose
 
Philippe Barthelemy
Honoraria - Astellas Pharma; Bayer; BMS; Gilead Sciences; IPSEN; Janssen-Cilag; Merck KGaA; MSD; Novartis; Pfizer; SEAGEN
Consulting or Advisory Role - AAA/Endocyte/Novartis; Amgen; AstraZeneca; Bayer; BMS; Eisai; Gilead Sciences; ipsen; Janssen-Cilag; Merck KGaA; MSD Oncology; Pfizer
Research Funding - IPSEN (Inst)
Travel, Accommodations, Expenses - BMS; IPSEN; Janssen-Cilag; Merck/Pfizer; MSD; Pfizer
 
Damien Pouessel
Honoraria - Astellas Pharma; AstraZeneca; Bristol-Myers Squibb; Ipsen; MSD Oncology; Pfizer/Astellas
Consulting or Advisory Role - Astellas Pharma; Bristol-Myers Squibb/Medarex; Merck; MSD Oncology; Pfizer
Research Funding - AstraZeneca (Inst); Bristol-Myers Squibb (Inst); Merck Sharp & Dohme (Inst); Roche (Inst); Seagen (Inst)
Travel, Accommodations, Expenses - AstraZeneca; Pfizer
 
Constance Thibault
Consulting or Advisory Role - Bristol-Myers Squibb
Research Funding - AstraZeneca (Inst)
 
Stephane Culine
Consulting or Advisory Role - Astellas Pharma; Bayer; Bristol-Myers Squibb/Pfizer; Janssen
Speakers' Bureau - AstraZeneca/MedImmune; Janssen; Merck; Takeda
Travel, Accommodations, Expenses - Ipsen; Janssen
 
Claude Linassier
No Relationships to Disclose
 
Alain Ravaud
Consulting or Advisory Role - AstraZeneca; Bristol-Myers Squibb; Eisai; Ipsen; Merck KGaA; MSD Oncology; MSD Oncology; Pfizer
Research Funding - Ipsen (Inst); Merck KGaA (Inst); Pfizer (Inst)
Travel, Accommodations, Expenses - AstraZeneca; Bristol-Myers Squibb; ipsen; MSD; Pfizer